Rachel Stephenson received a Bachelor of
Science, dual major in Biochemistry and Chemistry, followed by a Bachelor of
Science with First Class Honours in Chemistry at Massey University (New
Zealand). Her honors project centered on the innovative development of
hydrogels for the controlled release of bioactive peptides into the gut. She
pursued a PhD at Massey University, where she focused on developing synthetic
anti-cancer drugs based on cyclodextrins, a fascinating class of cyclic sugars.
After earning her PhD, she served as a Research Officer at the New Zealand
Veterinary Pathology Epicentre, Massey University, where she honed her skills
in diagnostic research. Then, she contributed as a Postdoctoral Fellow at the
Department of Diagnostic Medicine and Pathobiology at Kansas State University
(USA). Fuelled by a desire to merge her expertise in synthetic peptides with
her passion for vaccine development, she transitioned to the School of
Chemistry and Molecular Biosciences at the University of Queensland
(Australia). Here, her research is at the blended edge of health and medical
research, leading to the development of new adjuvants and vaccines across
fields of medicinal chemistry, nanotechnology, immunology, and medical and
agricultural biotechnology.
Research Keywords & Expertise
Group A streptococcus ...
Cyclic peptides as vac...
Peptide delivery syste...
Subunit vaccine develo...
Fingerprints
25%
Group A streptococcus glycoconjuagte vaccines
14%
Cyclic peptides as vaccine delivery platforms
Short Biography
Rachel Stephenson received a Bachelor of
Science, dual major in Biochemistry and Chemistry, followed by a Bachelor of
Science with First Class Honours in Chemistry at Massey University (New
Zealand). Her honors project centered on the innovative development of
hydrogels for the controlled release of bioactive peptides into the gut. She
pursued a PhD at Massey University, where she focused on developing synthetic
anti-cancer drugs based on cyclodextrins, a fascinating class of cyclic sugars.
After earning her PhD, she served as a Research Officer at the New Zealand
Veterinary Pathology Epicentre, Massey University, where she honed her skills
in diagnostic research. Then, she contributed as a Postdoctoral Fellow at the
Department of Diagnostic Medicine and Pathobiology at Kansas State University
(USA). Fuelled by a desire to merge her expertise in synthetic peptides with
her passion for vaccine development, she transitioned to the School of
Chemistry and Molecular Biosciences at the University of Queensland
(Australia). Here, her research is at the blended edge of health and medical
research, leading to the development of new adjuvants and vaccines across
fields of medicinal chemistry, nanotechnology, immunology, and medical and
agricultural biotechnology.
Well done!
